Pharmacogenomics

Papers
(The H4-Index of Pharmacogenomics is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Identification of RNA Modification-Associated Single-Nucleotide Polymorphisms in Genomic Loci for Low-Density Lipoprotein Cholesterol Concentrations39
Pharmacogenomics in Psychiatry – the Challenge of Cytochrome P450 Enzyme Phenoconversion and Solutions to Assist Precision Dosing27
miR-369-3p regulates the drug resistance of lung cancer cells by targeting PTPN1227
Evidence level for pharmacogenetic testing in antidepressant treatment: a systematic review25
Pharmacogenomics for Prader-Willi syndrome: caregiver interest and planned utilization25
Assessing patient understanding of pharmacogenomic test results: a qualitative study22
How to implement pre-emptive pharmacogenetic testing in the acute hospital setting19
Genetics and response to treatment with metformin for type 2 diabetes18
Pharmacogenomic variants affecting efficacy and safety of medicines acting on central nervous system among Sri Lankans16
Patient comprehension of preemptive pharmacogenomic results13
A systematic review of single nucleotide polymorphisms affecting allopurinol pharmacokinetics and serum uric acid level12
Rapid point of care testing: the next frontier in pharmacogenomics12
Assessing the Utility of Measurement Methods Applied in Economic Evaluations of Pharmacogenomics Applications12
0.25009703636169